IgE against rabbit allergens and the therapeutic use of recombinant human C1 inhibitor (rhC1INH) in hereditary angioedema

被引：0
|
作者：
Pijpstra, R.
Hack, E.
Baboeram, A.
Relan, A.
Haase, G.
Versteeg, S.
van Ree, R.
机构：
来源：
ALLERGY | 2010年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1185
引用
收藏
页码：445 / 445
页数：1
相关论文
共 50 条
  • [1] Clinical studies of recombinant human C1 inhibitor (rhC1INH) in patients with acute attacks of hereditary angioedema
    Nuijens, J.
    Verdonk, R.
    Giannetti, B.
    Visscher, S.
    van Doorn, M.
    Resink, T.
    Levi, M.
    Hack, C.
    Farkas, H.
    Obtulowicz, K.
    Caballero, T.
    Cicardi, M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (03) : 797 - 797
  • [2] A phase I study of recombinant human C1 inhibitor (rhC1INH) in asymptomatic patients with hereditary angioedema (HAE).
    van Doorn, M
    Nuijens, J
    Schoemaker, R
    Burggraaf, K
    Cohen, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P52 - P52
  • [3] Efficacy and safety of a weekly infusion of recombinant human C1 inhibitor (rhC1INH) for the prophylaxis of hereditary angioedema attacks
    Reshef, A.
    Moldovan, D.
    Obtulowicz, K.
    Visscher, S.
    Relan, A.
    ALLERGY, 2012, 67 : 353 - 354
  • [4] Efficacy of Recombinant Human C1 Esterase Inhibitor (rhC1INH) Across Anatomical Locations in Acute Hereditary Angioedema (HAE) Attacks
    Baker, James W.
    Bernstein, Jonathan A.
    Harper, J. R.
    Relan, A.
    Riedl, Marc A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB235 - AB235
  • [5] CLINICAL EFFICACY OF RECOMBINANT HUMAN C1 INHIBITOR (RHC1INH) IN NORTH-AMERICAN PATIENTS WITH ACUTE HEREDITARY ANGIOEDEMA ATTACKS
    Levy, R. J.
    Reidl, M.
    Lockey, R.
    Suez, D.
    Relan, A.
    Zuraw, B.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A97 - A97
  • [6] Combined efficacy analysis of recombinant human C1INH (rhC1INH) in the treatment of acute angioedema attacks in hereditary angioedema
    Pijpstra, R.
    Cicardi, M.
    Zuraw, B.
    Relan, A.
    Hack, E.
    Haase, G.
    Kaufman, L.
    Giannetti, B.
    ALLERGY, 2010, 65 : 13 - 13
  • [7] POPULATION PHARMACOKINETICS OF RECOMBINANT HUMAN C1 ESTERASE INHIBITOR (RHC1-INH) IN CHILDREN WITH HEREDITARY ANGIOEDEMA (HAE)
    Hayes, S.
    Farrell, C.
    Relan, A.
    Anderson, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S25 - S25
  • [8] Recombinant Human C1 Inhibitor (rHC1INH) Is Efficacious and Well Tolerated As Prophylaxis for Prevention of Hereditary Angioedema (HAE) Attacks: A Randomized, Phase 2 Trial
    Yang, William H.
    Li, H. H.
    Chase, Chevy
    Moldovan, D.
    Grivcheva-Panovska, V.
    Harper, J. R.
    Relan, A.
    Riedl, Marc A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB231 - AB231
  • [9] Immunogenicity assessment of recombinant human C1INH (rhC1INH)
    Baboeram, A.
    Relan, A.
    Hack, E.
    Mannesse, M.
    Oortwijn, B.
    Haase, G.
    Visscher, S.
    Pijpstra, R.
    ALLERGY, 2010, 65 : 445 - 445
  • [10] rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency
    Lilian Varga
    Henriette Farkas
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (02) : 143 - 153
12345